 Now, even the ultra conservative Fifth Circuit Court of Appeals concluded that these plaintiffs are too late to challenge the FDA's original approval of mifepristone 24 years ago. But the lower court rolled back the clock on science, overriding the FDA's evidence-based decisions in 2016 and 2021 with respect to its mifepristone regulations.